(Q41560968)

3 October 2017

1 reference

title

Growth hormone is safe in children after renal transplantation (English)

1 reference

3 October 2017

Benfield MR

1

1 reference

3 October 2017

Kohaut EC

series ordinal

2

1 reference

3 October 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

The Journal of Pediatrics

3 October 2017

published in

1 reference

3 October 2017

volume

131

1 reference

3 October 2017

issue

1 Pt 2

1 reference

3 October 2017

page(s)

S28-31

1 reference

Growth pattern and dietary intake of children with chronic renal insufficiency

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Factors predictive of sustained growth in children after renal transplantation. The North American Pediatric Renal Transplant Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Growth after renal transplantation in prepubertal children: impact of various treatment modalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Growth after conversion to alternate-day corticosteroids in children with renal transplants: a single-center study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Growth after renal transplantation: correlation with immunosuppressive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Growth hormone treatment in growth-retarded adolescents after renal transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Effects of growth hormone administration in pediatric renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Accelerated growth rates in children treated with growth hormone after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Expression of immunoreactive growth hormone in leukocytes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Demonstration of growth hormone (GH) receptor-associated tyrosine kinase activity in multiple GH-responsive cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Influence of growth hormone on the immunosuppressive effect of prednisolone in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970007-6

10.1016/S0022-3476(97)70007-6

7 January 2021

Identifiers

DOI

1 reference

3 October 2017

1 reference